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Introduction
Antibiotics or antibiotic substances are products
which can be extracted from a microorganism, and are anta-
gonistic to the development or life of a microorganism or
microorganisms other than the one producing it. In some
instances antibiotics can be classified as chemothera-
peutic agents since they fulfill the requirements of in-
hibiting or killing pathogenic microorganisms that have
invaded the body and are more toxic to the pathogens than
to the body tissues. In addition, a chemotherapeutlc
agent should be of known chemical composition; so most
antibiotics are ruled out as chemotherapeutlc agents due
to this qualification* In general, however, biological
products are not included as agents of chemotherapy.
The production of antibiotics by various
organisms and the practice of antibiosis is considered
to be a mechanism of preservation and siorvival an ong
competing microbes of various species with the tendency
to maintain equilibrium in a given microbial population.
Often the addition of a new species to a particular en-
vironment which has been in a state of microbial equili-
brium will result in the rapid destruction of the new
species due to the strong antibiotic effect of the pre-

existing organisms. For example, if a pathogenic organism
such as Salmonella typhosa is inoculated into fresh un-
sterllized soil, it will survive only a short time; "but
if the soil was previously sterilized to kill the anta-
gonistic organisms, S« typhosa survives for a much longer
period. This situation also occurs in water, sewage,
garbage, and other natural environments containing many
competing organisms. In some instances conditions may
favor the survival and development of the microorganism
that is added. In that case there will be an alteration
in the original equilibrium and certain pre-existing species
may be destroyed and eliminated from that environment. With
few exceptions, human and animal pathogens are unable to
survive for long periods in soil, water, garbage, etc.,
in part as a result of the phenomenon of antibiosis.
According to Waksman, ' ' the antagonistic effects
of one organism upon another were observed by many of the
early microbiologists. In 1876 Tyndall first noted the
struggles between mixed cultures of bacteria and Penicillium
finding that in some cultures the former outgrew and elimi-
nated the latter, and in other tubes the reverse was true.
In 1877 Pasteur noticed that anthrax did not develop in
susceptible animals that received simultaneous inoculations

of Bacillus anthracls and certain other bacteria. He stated
on peut introdulre a profusion dans un
animal la bacteridie charbonneuse sans que celul-
ci contracte le charbon; il suffice qu'au liquide
qui tient en suspension la bacteridie on ait associ
en m^me temps des bacteries communes,"
In 1879, De Bary remarked upon the observation that when two
organisms are grown in the same medium, sooner or later one
overcomes the other and even kills it.
There are several known methods for isolating anta-
gonistic microorganisms from various natural sources, such
as soil, sev/age, water, garbage, etc.
The soil enrichment method consists of adding
known living pathogenic bacteria to natural soil in a beaker
and incubating. From time to time samples of the enriched
soil are removed to test for the presence of organisms that
are antagonistic to the added test organism,
A second method is the bacterial agar plate method.
This consists of adding melted agar containing a suspension
of the test organism to a series of petri plates, each
having 1,0 ml of fresh or enriched soil, diluted from 1:100
to 1:10,000 times with sterile distilled water. The plates
are then Incubated and colonies of the soil organisms sur-
rounded by zones of inhibition of the test bacteria are
isolated and studied further for antagonistic activity.

The crowded plate method entails plating out
field or garden soil in low dilutions to produce deliberate
crowding by a large number of colonies. In this way po-
tential antagonists that are normally present in the soil
may manifest their presence by clear zones around the
colonies
•
The direct soil inoculation method consists of
inoculating agar plates with the test organism and incu-
bating for 24 to 48 hours. After good growth is obtained,
par tides of fresh or enriched soil are placed on the
sia?face of the plate; if antagonistic organisms are present
in the soil they will bring about killing or even lysis of
the original culture*
A fifth method is the "forced antagonism" method
by which one culture is continuously fed with another so
that the former is forced to develop the capacity to
destroy the first*
Antibiotics or extracts from these antagonistic
organisms have been isolated from a variety of sources.
They are by no means limited to products of microbial
origin, as antibacterial substances have been isolated
from higher plants (allicin from Allium sativum , inhibln
from honey, tomatin from the tomato plant, etc.), from

animals, (erythrin from red blood cells, lacterin from milk,
lysozyme from eggs, tears, and various organs^, and from
algae (chlorellin from species of Chlorella ) » These anti-
bacterial products from higher plants and from animals are
not antibiotics in the strict sense but have similar proper-
tie s •
The earliest antibiotic to be tested for its thera-
peutic value was pyocyanase which was obtained by ether
extraction of broth cultures of Pseudomonas aeruginosa
.
It was somewhat effective in the treatment of experimental
anthrax* The crude product is extremely toxic, but several
crystalline fractions have been prepared from the crude
product and these less toxic derivatives retain their anti-
biotic activity, especially against Gram-positive organisms.
The term "pyocyanase" is a misnomer since it does not act
like an enzyme.
In addition to pyocyanase, Pseudomonas aeruginosa
produces another distinct antibiotic, pyocyanine, which is
the characteristic pigment of this species. Pyocyanine
has been prepared synthetically, is strongly germicidal
against a variety of bacteria especially Gram-positive
organisms, but is too toxic for clinical use, Pyocyanine
was said to be more effective against younger cells, whereas

pyocyanase exerts its strongest action on older cultures.
Its mechanism of action as v;ell as part of its toxicity
is Involved in its oxidation-reduction equilibrium with,
its colorless reduced form. It forms a reversible redox
system and increases the oxygen consumption of both bac-
teria and red blood cells.
Another antibiotic of bacterial origin is tyro-
thricin which was isolated by Dubos in 1939 from an
aerobic, Gram-positive, sporeforming soil bacillus.
Bacillus brevis , Tyrothricin is composed of a mixture of
polypeptides and can be separated into two crystalline
components, gramicidin and tyrocidine, which are also
polypeptides. The composition of tyrothricin is 10 to
20 per cent gramicidin, 40 to 60 per cent tyrocidine,
and a residual portion containing substances that are
similar to gramicidin and tyrocidine plus a small inac-
tive fraction, which is partly lipoidal, Tyrothricin
is soluble in alcohol and insoluble in water. It is
active biologically chiefly against Gram-positive bac-
teria, but due to its toxicity, mainly a hemolytic action
it can be used clinically only for topical application
and in body cavities such as sinuses.
Gramicidin, one of the components of tyrothricin
is a polypeptide soluble in ether and in alcohol, but

insoluble in water, and it is thermolabile . It has strong
antibiotic properties both in vitro and in vivo mainly
against Gram-positive organisms and Neisseria , but cannot
be injected into the body due to its potent hemolytic
properties. It can be used topically and in body cavities
in man and other animals. Its m.echanism of antibacterial
action like that of pyocyanase is due to the increase in
oxygen consumption of bacterial cells in the presence of
gramicidin, that is, gramicidin stimulates the respiration
of susceptible bacteria. The action of gramicidin is in-
hibited in the presence of seriun and Gram-negative organ-
isms. This blocking is considered to be due to the
presence of phospholipids in the serum and in Gram-nega-
tive bacteria. In addition to increasing oxygen uptake
of susceptible bacteria, it appears also to block uptake
of phosphorus by these microorganisms. It is possible
that gramicidin prevents the conjoined storage of carbo-
hydrate and phosphorus in the bacterial cell.
The second component of tyrothricin, tyrocidine,
is strongly bactericidal and even bacteriolytic to some
organisms. Its chief action is against Gram-positive
bacteria, but it also is effective against many Gram-
negative bacteria. It is soluble in alcohol but in-
soluble in ether and is thermostable. Unlike gramicidin

tyrocidine has free amino groups and oan combine with
protein or partially hydrolyzed proteins. As a result
of this characteristic, the antibacterial action of
tyrocidine is markedly decreased in the presence of
protein, peptone, and similar substances. In the
presence of protein and related products, the predomi-
nant action of tyrothricin is due to the gramicidin.
The ability to lower surface tension adequately explains
both the bactericidal and bacteriolytic properties of this
antibiotic. Tyrocidine is also prevented from being used
parenterally by its hemolytic action. It differs from
gramicidin, which produces a slow prolonged hemolysis,
by producing a rapid, acute lysis of erythrocytes.
Gramicidin S (Soviet gramicidin) is produced
from a Russian strain of Bacillus brevls . Its properties
are more similar to tyrocidine than gramicidin. It is a
thermostable crystalline polypeptide and can be autoclaved
without appreciable loss of potency. Like tyrocidine and
unlike gramicidin, it contains free amino and carboxyl
groups and has been reported to be active against Gram-
positive and certain Gram-negative organisms including
Proteus vulgaris and Escherichia coll . It has been used
effectively in the clinical treatment of infections in
gunshot wounds of soft tissues, in severe burns, abscesses

of the abdominal wall. In pleijral and peritoneal Infections,
and in anaerobic infections. The potency'- was not diminished
in the presence of pus, it did not irritate the tissues,
and had a favorable effect on regeneration and epitheliza-
tion.
Other antibiotics extracted from bacterial sources
include the seven relatively recent separate substances
extracted from Bacillus subtilis« These are subtilin,
subtilysln, endosubtilysin, bacitracin, bacillin, eumycin,
and trypanotoxin. In this group only two show promise of
taking their place among the family of clinically useful
antibiotics. These two are subtilin and bacitracin*
Subtilin is obtained by extraction of cultures
of B» subtilis with normal butanol. Best production is
obtained by adding 0.3 per cent 1 {-/-) asparagin D plus
iron, manganese, and copper to the basic medium. In
general G-ram-positlve organisms and Neisseria are most
susceptible in vitro . It is also active against Trypano-
soma equiperdum and Entamoeba histolytica in vitro . It
is not a highly stable compound and rapidly loses potency
on storage. It has been shovm to have high protective
and therapeutic value in experimental infections with
Staphflococcus
.
Streptococcus
,
pneumococcus , and anthrax
wi
bacillus. Its mode of actj.on is unknovm although It has
been found to lower surface tensions of water or alcohol
to an equal extent as gramicidin. The general toxicity
of subtilin is low.
Bacitracin, a polypeptide by all chemical tests,
is a relatively nontoxic, highly active, stable (on re-
frigeration) antibiotic. It was originally extracted
from B. subtilis by Johnson, Anker, and Meleney in 1945,
and was found by them to have low toxicity v/hen injected
parenterally into mice, guinea pigs, or rabbits, or by
subcutaneous, cutaneous, or conjunctival application in
hiamans. Its antibacterial activity is chiefly against
Gram-positive bacteria and Neisseria in vitro and has
protected mice and guinea pigs against hemolytic strepto-
coccus and certain Clostridia in experimental infections
by in vivo tests. Its pharmacological properties such as
rate of absorption by various portals of entry, its blood
levels and diffusibility Into other body fluids and tissues,
its acute and chronic toxicities, and its routes and rates
of excretion have also been studied. It was determined
that appreciable levels were attained rapidly by various
parenteral routes, but that bacitracin was destroyed in
the gastro-lntestlnal tract when given per os . The serum
levels attained by intramuscular and subcutaneous in-
jections were maintained at appreciable levels for con-
fi
siderable periods, but intravenous Injections gave high
levels followed rapidly by a rapid drop. Excretion was
largely in the urine. It did not penetrate the red blood
cells nor did it diffuse readily into the spinal fluid.
The acute and chronic toxicities v/ere relatively low.
Bacitracin is being produced on a pilot plant scale but
the maximum yields are still only 40 units per mg. These,
however, are only about one half as toxic as the previous
maximum of 25 units per mg, indicating that the toxicity
probably will decrease with greater purification.
A third antibiotic from B. subtilis
,
bacillin,
was isolated in 1946 by Foster and Woodruff. Despite
its potent antibacterial properties against a wide range
of Gram-positive and Gram-negative organisms, its toxicity
proved to be too great for clinical use. It is also inac-
tivated by a wide variety of substances in nature*
The other antibiotic substances from B. subtilis
are either of too great toxicity or too insoluble for
practical use in the treatment of clinical disease. Some
hope is seen for eumycin in the treatment of tuberculosis
.
It has strong antagonism against the tubercle bacillus
and it has been suggested that its toxic factors may be
separable from its antituberculosis properties.

other prominent antibiotics from bacterial sources
are the very recently isolated polymyxin from Bacillus
polymyxa and aerosporln from Bacillus aerospora . These
two are considered to be identical and are active against
Gram-negative organisms. They have low toxicity for
higher forms of life and microorganisms show little tendency
to develop resistance to them.
A number of antibiotics have been proc?uced by the
actlnomycetes
,
among which the most investigated ones are
actinomycetin from Streptomyce s albus, actinomycln from
S» antibiotlcus
,
proactinomycin from Nocardia gardneri
,
streptothricin from S» lavendulae , and streptomycin from
S. griseus,
Actinomycetin has some bad features, such as
greatly diminished antibiotic activity in the presence of
complex culture media, and the presence of the living
Actinomyces is usually essential to produce death and
lysis of the susceptible Gram-negative and Gram-positive
bacteria.
Actinomycln Is a highly potent antibiotic, anta-
gonistic to all species of bacteria tested and many fimgl,
and is very stable to heat. It is, however, unsuitable
for clinical purposes since it is only slightly soluble in

water and very toxic to animals.
Proactinomycin is very active against many Gram-
positive bacteria and somewhat less active against some
of the Gram-negative bacteria. It is soluble in water
as well as some organic solvents, and is thermostable,
but has limited therapeutic value due to its toxicity,
Streptothricin is far more valuable than the
other antibiotics already extracted from Actinomycetes
with the exception of streptomycin. It is soluble in
water, thermostable, highly active against various Gram-
negative and some Gram-positive bacteria, and is of
limited toxicity to animals.
Streptomycin is the most investigated, most
used, and probably the most therapeutically effective
antibiotic isolated from the Actinomycetes , Its anti-
bacterial spectrum is broader than that of streptothricin
being active against a wide variety of Gram-negative and
Gram-positive bacteria, and it is less toxic than strepto
thricin. It is also very thermostable and highly soluble
in water. In acid solution it is hydrolyzed into two
inactive fractions, streptidine and streptobiosamine, a
disaccharide. Although streptomycin is stable to heat,
its activity can be destroyed by other mans, such as
extremes of acidity or alkalinity (maximal activity is

at pH 8,). In vivo , the outstanding therapeutic uses have
been against tularemia, meningitis caused by certain Gram-
negative bacilli, especially Hemophilus influenzae . It
has been effective in the treatment of urinary and res-
piratory infections caused by Gram-negative bacilli, such
as H« influenzae , Klebsiella pneumoniae , Escherichia coli ,
and others. Definite clinical improvement has been ob-
served with the use of streptomycin in certain forms of
tuberculosis. The mechanism of action of streptomycin
against susceptible organisms has not been explained.
It differs from the action of penicillin, which is most
effective against susceptible bacteria at the stage of
most rapid cell division. A bad feature of streptomycin
is the tendency for susceptible orgfr.nisms to become in-
creasingly resistant at a rapid rate generally without
loss of virulence.
Other substances have been obtained from S. griseus
in addition to streptomycin, Grisein is similar to strep-
tomycin but has a narrower antibacterial spectrum, and
actidione is a poor antibacterial substance, but is active
against many yeasts, including Cryptococcus neoformans ,
Many antibiotics have been isolated from various
species of fungi, mainly among the genera Fenici Ilium and
Aspergillus , Prominent among these and among all anti-

biotlcs from all sources is penicillin which is produced
from the molds, Penicilliiam notatum , and Penicl Ilium
chrysop;enum « Pour distinct penicillins, P, G, X, and
K with different chemical formulae have been prepared.
The most active and most comm.only used clinically is
penicillin G, Penicillin is effective against Gram-
positive bacteria and the NeisserisTe ^ but it has very
little action against other Gram-negative bacteria except
in very high concentrations. The toxicity of penicillin
is extrem.ely low. It is fairly stable on storage but
is rapidly destroyed by heat, extreme acidity and extreme
alkalinity. Its antibiotic activity is inhibited by ions
of heavjT" metals, strong oxidizing agents, cysteine, and
certain enzymes, such as clarase, taka-diastase, and
penicillinase. Penicillins have little or no effect on
resting cells but have a vigorous bactericidal effect on
multiplying cells©
Other antibiotics produced by P. notatum are
notatin (also known as penatin, E. coli factor and peni-
cillin B) and notalysin. The action of notatin consists
of the oxidation of glucose to gluconic acid with the
production of hydrogen peroxide, and the antibacterial
action is due to the hydrogen peroxide*

Another antibiotic from molds has been isolated
from several species, and as a result, has many names. It
is variously known as patulin, patulum, claviforme, clavl-
formin, expansin, clavatin, and clavacin. It is effective
against both Gram-positive and Gram-negative bacteria as
well as many fungi. Its toxicity, however, is too great
for clinical use.
Citrinin, obtained from Penici Ilium citrinum and
Aspergillus candidus
.
is effective against Gram-positive
bacteria with little or no effect on Gram-nagative organisms.
It has lim.ited toxicity for animals.
There are several antibiotics produced by various
species of Aspergillus
. Pour distinct antibiotics can be
isolated from A. fumigatus; they are fumigatin, gliotoxin
(also produced by species of Trichoderma
. and gliocladium)
,
spinulosin (also extracted from A. spinulosum ) . and fuml-
gacin (known also as helvolic acid).
Fumigatin shows practically no action on Gram-
negative and only limited action on Gram-positive bacteria,
and is therefore, not an effective antibiotic.
Gliotoxin is active against various bacteria and
fungi but is toxic to animals.

Spinulosin is a very weak antibiotic agent.
FumiGacin is active against Gram-positive bacteria,
and although less toxic than many other antibiotics, it
is too toxic for therapeutic use.
Some of the other better known antibiotics from
aspergillar sources are aspergilllc acid from A. flavus
and aspergillin from A. niger > Aspergilllc acid is active
chiefly against Gram-positive bacteria, but also is active
against many Gram-negative organisms. It is too toxic for
clinical use. Aspergillin is effective against both Gram-
positive and Gram-negative bacteria, is nontoxic, but is
apparently water insoluble.
With the continued use and study of the various
antibiotics the problem of resistant strains, due to
repeated exposures to sublethal doses of the drug, be-
comes increasingly prominent. This problem was particular-
ly evident with the use of streptomycin, since m.any ori-
ginally susceptible strains developed a rapid and permanent
rise in resistance to it without an accompanying decrease
in virulence. This resistance was in some Instances so
rapid and so permanent that some strains became not only
resistant to streptomycin but actually dependent upon its
presence in the medium as an essential or accessory growth
factor. '^^''^^
II
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For penicillin the problem of resistance was not
quite as serious, since the resistance does not ordinarily
rise as rapidly; and simultaneous with the increase,
there is many times a drop in virulence. There are, how-
ever, many strains among susceptihle species which are
naturally resistant, and susceptible strains may become
resistant during expeeure to sublethal doses without
loss of virulence.
Theories have been advanced regarding the
mechanism of the develooment of resistance, and these
-7
J- rr.
have been summarized by V\rak:sman into three m.ain mechan-
isms of resistance among bacteria* These are adaptive
mechanism (A), selective mechanism (S), and mutating
mechanism (M) . The adaptive mechanism consists of the
production by the organisms of new enzyme systems or
new metabolic mechanism.s to replace those interfered with
by the presence of the antibiotic or by some other related
phenomenon, such as the production of inactlvators of the
antibiotic, the outstanding example of this being penici-
llinase. The selective mechanism consists of the elimi-
nation of susceptible cells from a given bacterial popu-
lation by the antibiotic, and as a result the more re-
sistant individual cells survive and dominate the bac-
terial population. The mutating mechanism, as the name

implies, consists of the arising of resistant mutations
from a susceptible parent strain*
The overcoming of resistance to antibiotics is
one of the major problems confronting v/orkers in various
fields of science. Since one possible solution to this
problem is the use of more than one antibiotic either
simultaneously or successively, it was considered of
interest to study the use of resistance to a new anti-
biotic, bacitracin, as compared with penicillin. This
study is concerned with the rise of resistance of
Staphylococcus aureus (Micrococcus aureus ) following
exposure to penicillin and bacitracin, the existence
or nonexistence of cross resistance, and the decrease
in resistance following removal of the resistant strains
from the antibiotic.
««
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HISTORY
Nicolle (1907) revealed that cultures of BacillTis
subtllis were antagonistic toward some of the Clostridia,
and that filtrates of B« subtilis v;ere active af';ainst many
bacteria such as Pneumococcus , Glanders bacillus. Anthrax
bacillus. Typhoid bacillus, Shigella, Salmonella suipestifer
.
Staphylococci, Vibrio cholerae . Bacillus pestis , and others.
Pringsheim (1920) discussed the antibiosis of
various organisms showin^^ that many bacteria possessed the
ability to inhibit other bacteria.
57Rosenthal (1925) found that Bacillus mesentericus
had a lytic activity on various thermophilic bacteria, for
example staphylococci. Salmonella typhosa ^ and Vibrio cholerae
both in broth and on gelatin plates.
Rosenthal (1925) also showed that Tyrothrix
scaber was active against Vibrio choler'ae
, and in the same
year found it to be active a^^ainst other thermophilic
bacteria as v/ell as having a lytic effect on these organisms.
Van Canneyt(1926) revealed that Bacillus subtilis
overgrew Mycobacterium tuberculosis when the latter organism
had been previously cultured on a potato medium, and lessened

the f;^rowt>i of the tubercle bacillus so that it was almost
gone in five to seven weeks.
AO
Rakleten, Rakleten, and Duff (1936) reported
that several strains of bacilli in the subtills group were
able to adsorb and inactivate Staphylococcus bacteriophage
in 18 hours at 35 C, and once inactivated the phage could
not be freed by the addition of susceptible staphylococci
or by lysis of the adsorbing bacilli. The possible mechanism
of this action was discussed. In addition these workers were
able to inactivate a virulent strain of vesicular stomatitis
by contact wi. th Bacillus subtills for 15 hoi.u?s at 35 C,
Rosenthal (1941) studied the inhibitory and
lytic action of 31 strains of the subtilis-mesentericus
group against Gram-positive and Gram-negative organisms.
Of the 31 strains, 7 were inactive, 5 were active against
Gram-positive bacteria only, and the remaining 18 were active
against both. The living Gram-positive bacteria were more
susceptible to the inhibitory action than the living Gram-
negative bacteria, while the dead Gram-negative organisms
were more susceptible to the lytic activity than the dead
Gram-positive organisms.
Heilman and Herrell (1941) showed that gramicidin
was strongly hemolytic to rabbits 'or sheep's erythroc^rtes
whether in tissue culture, on a blood plate, or in blood broth.
I
23
In 1941 Eeilman and Herrell also studied the mode
of action of gramicidin and tyrocidin. The action of tyro-
cidln was concluded to be a lowering of surface tension in
the manner of a detergent. Gramicidin was considered to
have a similar action. It is now known that at least part
of the action of gramicidin is effected "by increasing the
ocygen consumption of the organisms.
Robinson and Molitor (1942) investigated the
toxicity of gramicidin, tyrocidin, and tyrobhricin in rats
and mice and other experimental animals. In rats and mice
oral doses were non-toxic up to 1 g per kg, possibly due
to its insolubility. Intravenous doses of gramicidin were
lethal in 1 to 50 mg per kg, of tyrothricin 2.5 mg per kg,
and of tyrocidin 15 mg per kg. These observations were
xyarried for from 1 to 4 days. Intraabdominally tyrothricin
caused death at 30 mg per kg, v^hereas gramicidin and tyro-
cidin killed at 40 mg per kg. All three drugs showed greater
toxicity by both intravenous and intraabdominal routes when
observations were recorded up to seven days.
Lewis, Dimick, Peustel, Fevold, Olcott, and Frankel-
conrat (1945) ^ modified gramicidin by mixing 10 parts of
5 per cent solution of gramicidin in 95 per cent alcohol
with 1 part of 1 normal sodium hydroxide and 5 parts of
I
1
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commercial 40 per cent formaldehyde and maintaining at
53 C for tvTO days. The formaldehyde-modified gramicidin
was less than one-twentieth as toxic by intraabdominal in-
jections into rats and less than one-tenth as hemolytic as
untreated gramicidin. It still maintained its original
antibacterial potency,
Rees and Reardon (1944) showed that penicillin
in a concentration of 100 units per ml could be used to
eliminate Streptococcus hemolytic vs as a contaminant from
II I II 563 medium in the endeavor to culture Entamoeba
histolytica
,
and that It was useful to eliminate bacteria
from cultures of Trichomonas vaginalis .
Van Dyke (1944) studied som.e pharmacological
properties of crystalline penicillin G and determined that:
(1) 0,15 M sodium penicillin produced no hemolysis of
washed rabbit erythrocytes after 3 hours at 37 C, but pro-
duced som.e changes in the red blood cells after 17 hours;
(2) there was no appreciable adsorption of sodium penicillin
on red blood cells after two hours ' incubation at 37 C of
erythrocytes in a medium containing sodium penicillin G;
(3) no changes in oxygen consumption of yeast cells, duck
red blood cells, and rat liver slices, as a result of ex-
posure to penicillin for over tv;o hours; (4) high concen-
trations of scdium penicillin caused moderate reversible
f
i
k
reduction In amplitude of beat of frog's heart but had no
effect on the rate; (5) it had no effect on isolated f^uinea
pig ileum or uterus; and (6) extremely high intravenous con-
centrations in mice caused only very slight, transient toxic
effects,
Eondi and Dietz (1944) reported a method of
determining penicillinase production by a test organism.
The organism is grown for 4 days in broth and mixed with
penicillin in proper dilutions and amounts. The m.ixture
is then placed in a penicylinder cup on agar plates pre-
viously seeded with a penicillin sensitive organism. If
there is no zone of inhibition and a control cup shows
inhibition of the penicillin sensitive organism, penicillin-
ase v/as producedo
9
Bondi and Dietz (1945) studied 115 strains of
Staphylococcus, not all pathogenic, hemolytic, or pigmented,
isolated from patients. The 115 strains v/ere assayed for
penicillin sensitivity and then penicillinase determinations
were m.ade. Strains that were inhibited by 0,15 units of
penicillin per ml or less (99 of the 115 strains ) did not
produce penicillinase, v/hereas strains (the remaining 16)
that required more than 0,15 units per ml for inhibition did
produce penicillinase.
4
^5
Perls tein and Llebmann (1945) produced an anti-
penicilllnase immune serum by injecting rabbits with
penicillinase, and this serum protected penicillin (1000
units) in vitro from up to 50 units of penicillinase for
one hour, vhereas normal serum protected against only
3 -units of penicillinase under similar conditions.
18
Gots (1945) developed a simplified method of
determining penicillinase production by an organism.
The method consists of inoculating a penici llin-agar
medium with a penicillin sensitive organism, and then
streaking the test organism over the surface of the
plate after it has hardened. The test organism is
streaked from the center out like the spokes of a
wheel, and if the penicillin sensitive organism grov/s
in the vicinity of the streak, it indicates penicillinase
was produced and diffused into the medium. The v/idth of
the zone of growth by the penicillin sensitive organism
is a rough estim.ation of the amount of penicillinase
produced.
Benedict, Schmidt, and Coghill (1945) ^ jiested
several enzymes for penicillinase activity and found only
two, concentrated pumpkin protease and high diastatic
malt syrup, that had activity* Also numerous organisms
in the general Serratia
,
Escherichia , Aerobacter , Pseudo -
monas
,
Vibrio
,
Flavobacterium
,
Proteus , and Bacillus y;ere

tested for penicill-lnase production and v/ere found to pro
duce only a v/eak exocellular penicillinase. The optimal
pH of penicillinase was reported as 6.5 to 7.0 at 25 C,
The destruction of penicillin was rapid, more than half
of 60,000 units being destroyed in 8 minutes,
Katznelson (1942) found that Bacillus subtilis
produced a thermostable substance active against Hhizoc -
tonia soloni , and Humfeld and Peustel (1943) produced
antibacterial extracts from two species of Bacillus
subtilis grown on asparagus juice medium.
Jans en and Hirschraan (1944) reported on the
extraction of a substance (subtilin) from cultures of
Bacillus subtilis , A synthetic medium was employed to
eliminate excessive organic substances, and four trans-
plants were made for best subtilin production. The
three preliminary subcultures v/ere incubated s.t 35 C
for 24 hours, and the final transplant was made into a
flask with the desired voluire of medium using a 4 per
cent inoculum. The final subculture was incubated, and
on the 3rd and 6th days tests were made fot? the presence
of subtilin. To test for subtilin a few drops of 1.0
per cent alcoholic solution of ferric chloride were
added to 5,0 ml of the cultu.re, A deep blue color
developed if there was high subtilin activity in the
culture, and no color developed wj. th little subtilin

activity. Best production v;as obtained by addition of
0.3 per cent 1 (-/•) asparagine D plus Iron, manganese,
and copper to the basic medium. A crude dry'form of
subtilin was extracted and purified. Antibacterial
properties af;;ainst test organisms and in standard test
media were performed using Staphylococcus aureus
(PDA #209) and Micrococcus conglomeratus (Merck "M.Y.")
in nutrient broth and Lactobacillus easel in a yeast
extract-glucose broth. Studies on stability showed it
to be relatively unstable with rapid loss of activity
on storage. There was a far greater loss of activity
if the material was stored (either in dry form or in
solution) in the light than if it was stored in the dark.
50
Ram.on and Richou (1945) studied the action of
a substance extracted from Bacillus subtilis , which was
termed subtilin, on diphtheria, staphylococcus, and
tetanus toxins. These toxins were either modified or
destroyed by exposure to subtilin.
Olivier, de Saint-Rat, Bonet-Maury, and Blanchon
(1945)^^^ studied the effect of ingestion of cultures of
Bacillus subtllis in the treatment of diarrheas due to
bacteria, and obtained good results. Treatment of
cystitis and pyelonephritis due to colon bacillus by
ingestion or bladder injection of B. subtllis cultures
also gave favorable results. The mechanism was considered
4I
to .be due to the replacement of the patho'-en by B. subtilis
since it grew more rapidly, and this was follov/ed by the
subsequent disappearance of B« subtilis as v/ell,
Ramon, Richou, and Ramon (1946) extracted and
partially purified a substance from Bacillus subtilis
which they showed by a tube method to be antagonistic
in vitro to the diphtheria bacillus, anthrax bacillus,
and cocco-bacilD.us of pseudotuberculosis •
Salle and Jann (1945) employed a cup plate or
disc method to determine the antibacterial spectri-m of
subtilin in dilutions running from 1:1000 to 1:10,000,000.
They considered as susceptible those organisms that were
inhibited in dilutions of l:1000or higher and as resistant
organisms those that were not inhibited at 1:1000. In
general Gram-positive bacteria were susceptible while
Gram-negative bacteria were resistant.
Anderson, Villela, Hansen, and R4ed (1946)''- found
that subtilin lowered the surface tensions of water or
alcohol to an eqiml extent as gramididin, but unlike
gramicidin it had no effect on red blood cells. Studies
on certain protozoa revealed that it produced cytolysis
of Trypanosoma equiperdum in vitro but was ineffective
in protecting mice from an infection by T. equiperdian ;

It was inactive in vitro and in vivo attains t Leishmania
donovani; it was very active aj^ainst Entari.oeba histolytica
in vitro and also cleared one Macacis rhes^^s of Infection
for 3 weeks following the administration of 1 g per kg
total oral dosage of subtilin in 10 days; and it was also
active against Lactobacillus plantarim in vitro
,
particu-
larly in the presence of para-aminobenzoiX acid which
enhanced this action of subtilin. Toxicity studies in
mice shov/ed the intravenous L D^^ to be 60 3 mg per
kg as compared to gram.icldin whose L D50 is 1«5 mg per
kg. Subcutaneous and intragastric L D50 of subtilin were
670 30 mg per kg and 5 g per kg respectively,
Salle and Jann (1946) determined the toxicity
index subtilin as 0.05, using the highest dilution of
subtilin that killed embryonic tissue pfter 10 minu.tes*
exposure at 37 C as the numerator, and using the highest
dilution killing Staphylococcus aLireus (P.D.A. strain)
under the same conditions as the denominator. They also
defined a unit of subtilin as the amount present in 1.0 ml
of the highest dilution (expressed in mg) capable of killing
Stanhylococcus aureus (F.D.A. strain) in 10 minutes at 37 C.
Salle and Janr (19§6) were able to protect and
cure mice from experim.ental infections of lethal doses of
pneijunococcus Type III by injections of 0.5 units every four

hours or less frequently for two to three days. There
were no observable toxic reactions from the subtilln,
Salle and Jann (1946)^^ treated ^^-^ii^ea pigs that
were experimentally infected with Bacillus anthracia by
intraabdominal injections of subtilin and were able to
prolong the lived of the guinea pigs and possibly cure
them,
Salle and Jann (1946)^*^ protected and cured mice
of experimental infections of Streptococcus pyogenes by
Injections of one unit of subtilin every 3 hours, later
increasing to two units at longer intervals, for approxi-
mately 30 hours,
Vi/ong, Hambly, and Anderson (1947 used a modi-
fied Dubos and Davis Medium for the demonstration of the
antibiotic activity of subtilin against Mycobacterium
tub erculosis , Using this medium control cultures grew
in three days, while subtilin inhibited the growth of
M« tuberculosis as follov/s: final concentrations of
subtilin from 1:20,000 through 1:400,000 inhibited growth
for 12 days; 1:800,000 inhibited growth for 4 days, and
1:1,600,000 inhibited growth for 3 days, so that there
was grov/th on the fourth day after inoculation. Material
taken from these cultures for guinea pig inoculation

revealed that a dilution of 1:20,000 prevented tubercle
bacillus infection, 1:40,000 and 1:80,000 sometimes pre-
vented infection, but hif];her dilutions did not prevent
infection,
Sal]e (1947)^'^ discussed subtilin in regards to
methods of preparation, physical and chemical properties,
including stability, antibacterial spectrum, toxicity,
and in vivo activity,
Vallee (1945) studied the action of extracts
of Bacillus subtilis (these extracts v/ere termed subtilysin)
against Vibrio septique and Bacillus oedematiens . He
found that by mixing the extracts with the cultures for
short periods of tim.e prior to injection into guinea pigs
did not protect the animals, but when subtilysin was in-
cubated with cultures of Vibrio septigue or B, oedematiens
for longer periods the siirvival rate of the guinea pigs
was up to five times as long as the controls,
Buggs, Bronstein, Eirshfeld, and Pilling (1946)^^
found a heat labile factor in human sera that was able to
inhibit B. subtilis in varying dilutions up to 1 to 32,
These same were tested against Staphylococcus aureus , but
none were inhibitory for that organism,
Foster and Woodruff (1946)-'-^ isolated bacillin, a
new antibiotic from Bacillus subtilis , and distinguished

this antibiotic from tyrothricin, subtilin, simplexin,
and bacitracin. Bacillin revealed antibacterial proper-
ties aj^ainst a wide spectriun of Gram-positive and Gram-
negative bacteria, nut its toxicity in mice proved to
be c^reater than its protective capacity against the
pnetimococciis •
Poster and Woodruff (1946)'^'^ shov/ed that anti-
bacillin, a naturally occurring inhibitor of bacillin,
was present in a wide variety of organic material, such
as brain-heart infusion, tryptone, rabbit blood, rabbit
serum, many bacteria, yeasts, molds, and actinomycetes
•
Burdon and Johnson (1947) reported on the
present status of eumycin, another antibiotic isolated
from Bacillus subtilis > It was stated to be anta^ionistic
to pathogenic fungi and to the related actinomycetes, as
well as mem.bers of the genera Mycobacterium and Coryne-
bacterium . Methods of production and extraction, chemical
and physical properties, and toxicity were discussed. It
was considered too toxic for clinical use although som.e
hope v/as held for its use against tuberculosis,
Johnson, Anker, and Meleney (1945) extracted a
substance unlike subtilin from Bacillus subtilis and
termed it bacitracin. The physical, chemical, pharma-
cological and antibiotic properties were investigated.

It was reported to have low toxicity when injected sub-
cutaneonsly or intraabdominally 3nto mice or guinea pigs,
intravenously into rabbits, or by subcutaneous, cutaneous,
or conlimctival arpli cation in humans. A standard unit
was designated and an in vitro antibacterial spectrum was
determined. The antibacterial tests in broth revealed
considerable activity against hemolytic streptococci of
Groups A, B, C, and G, and some activity against Strepto -
coccus Group D, Staphylococcus aureus
,
pne-'jimococ cus Types
I, II, and III, and some of the war wound anaerobic bacilli.
By the agar plate penicylinder method gonococci and meningo-
cocci showed a zone of inhibits on, but certain Gram-negative
bacilli were not inhibited. In vivo tests in mice and
guinea oigs shov/ed considerable protection against hemolytic
streptococci and Clostridium perfringens or Clostridium
_se£ti_cum. Local application to streptococcal or staphylo-
coccal Infections in a small number of human cases gave
results comparable to those with locally applied penicillin.
Scudi and Antopol (1947)^^ studied the acute and
chronic toxicities of bacitracin and revealed that the
L D^Q in mice was approximately 200-300 mg per kg intra-
venously or intraabdominally, the subcutaneous L D^^ was
about 2500 mg per kg, and the oral L D^q was approximately
7,5 g per kg. The L D^q was about the same for active and

inactivated bacitracin. The toxicity was found to be
very low when small doses were given over an extended
period of time, despite the fact that the total dosage
was well over the L D^.^,50
Scudi, Cli^t, and Krueger (1947)^'^ investigated
the absorption and excretion of bacitracin in the dog by
administrating the antibiotic by various routes and taking
blood, urine, and feces specimens as assay materials for
bacitracin at various intervals. The results showed that:
(1) after oral administration no detectable bacitracin
could be found in the serum or urine and only 5 per cent
could be recovered in the feces indicating destruction of
the antibiotic in the gastro-intestinal tract; (2) after
a single subcutaneous injection maximal serum concentra-
tions occurred in one hour and significant amounts were
still present after 7 to 8 hours; (3) after intrarauscular
injection higher concentrations were obtained than those
after a subcutaneous injection, and the duration of appre-
ciable levels was about the same; (4) after an intravenous
injection very high serum levels were achieved rapidly
(as high as 15 units per ml) followed by a rapid drop;
(5) no toxic effects were observed in the oral, subcutan-
eous, or intramuscular experiments, but transient slightly
toxic effects were noted after high concentrations were

administered Intravenously at a rapid rate; and (6) baci-
tracin did not penetrate the red "blood cells nor freely
enter the spinal flLild, and recovery in the urine was
variable but generally increased in direct ratio to the
dose administered,
Hoff, Stanley, and Bennett (1947)^^ described a
cup plate method for bhe assay of bacitracin, the best
results being obtained with Micrococcus flavus as the
test organism. An eleven mm diameter zone was noted
with 0,1 units per ml and a 21 mm zone with 4,0 units
per ml*
Goorley (1947)-^'^ investigated some of the chemical
and physical properties of bacitracin in an attempt to
produce it on a pilot plant scale. Preparations were
being made with a purity of about 30 to 40 units per mg.
These preparations had an M L D for 20 g mice of about
300 units when injected intraabdominally, were completely
soluble in water, and had onl3'- a slight pressor effect
when 1000 units per kg vrere injected intravenously into
dogs. The material containing 40 units per mg v/as about
one half as toxic as the previous material containing
25 units per mg. Solubilities, methods of precipitating
and purifying, and chemical tests (indicating that it is
a polypeptide) were discussed.

Johnson, ArJ^er, Scudi, and Goldber.^;; (1947) shov/ed
that smooth colonies of Bar-lllus auht5-lls yielded little
or no bacitracin while rough strains yielded up to 4 to
8 units per ml of "broth. Some substrains gave higher
yields than the parent strains. Studies were made on
the method of extraction and purification, and of the
stability of the purified product imder various conditions.
In vivo studies revealed that subcutaneous injections of
bacitracin were highly effective in the treatment of mice
previously infected with 10,000 MLD of hemolytic strepto-
coccus or pneumococcus Types I and II, Acute and chronic
toxicity studies and absorption and excretion studies were
also discussed.
Meleney and Johnson (1947)'^^ observed the effects
of local application of bacitracin to 100 cases of surgical
infections, such as furuncles, deep and superficial ab-
scesses, carbuncles, infected sebaceous cysts or wounds,
ulcers in various locations, styes, and impetigo, and
found that the majority of these cases gave either ex-
cellent or good results,
Hoff, Bennett, and Stanley (1947)^^ described a
cylinder cup method for the assay of bacitracin.
Scudi, Coret, and Antopol (1947)^^ studiedi the
toxic effects of intramuscular injections of commercial

bacitracin in dogs and monkeys for 4 weeks and 5 to 6
weeks respectively. There were practically no chanses
observed in the blood and urine of dogs during and at
the end of the course, v/hile there were some slight
changes noted in the blood and urine of the monkeys.
Autopsies revealed no macroscopic and slight microscopic
changes in certain organs of the dcgs, but there v.-cre
definite gross and histological alterations in the
monkeys.
Eagle and Fleischman (1948) •'•'^ studied the relative
antisyphilitic activity of penicillins P, G, K, and X,
and bacitracin. They found that penicillin G far sur-
passed the other penicillins as well as bacitracin in
the inhibition of the Reiter strain of Treponema in vitro
,
in the cure of an established syphilitic infection in
rabbits, and in the abortion of a syphilitic infection
during the incubation period.
Eagle, LTusselman, and Plerschman (1948)^^ revealed
that subtilin was far less active than either bacitracin
or penicillin in producing either complete or partial
inhibition of the Pieiter strain of Treponema, They noted
that by increasing the concentration of bacitracin they
were able to cause a m.ore rapid death of the Reiter strain.
Bacitracin v;as far more effective than subtilin in the

treatment of experimentally produced syphilitic chancres
in rabbits.
Against Streptococcus pyoi^enes (C-203) subtilin,
however, was nearly as active as penicillin, which was
20 times as active as bacitracin.
Anker, Johnson, Goldberg, and Meleney (1948)^
reported on the production, concentration, and purifi-
cation of bacitracin. The m.aximum purity is still a
crude product of 30 to 40 units per mg. They also re-
ported on various chemical properties of the crude product
Bond and Nook (1948) described a penicylinder cup
plate method for determining the concentration of baci-
tracin in body fluids; it was reported to be sensitive
to 0.02 units per ml.
Earanelkamp and Maxon (1942)'^^ showed that strains
of Sta hylococcus aureus that were originally highly sus-
ceptible to penicillin (most were inhibited between 0,02
units and 0,08 units per ml) developed increasing re-
sistance after repeated contact with sublethal doses of
penicillin. One strain developed a 64-fold resistance
in 54 days. This rise in resistance by contact with.
sublethal doses occurred both in vitro and in vivo.

Schnitzer, Camasni, and Riick (1943) found that
small colony variants (p;-forms) of Staphylococcus albus
developed resistance to penicillin, whereas the S-forn
was still susceptible. This v/as, however, shov/n to be
a non-specific drug resistance as these organisms also
became resistant to other chemicals.
McKee and Hoijck (1943)'^''' showed that althou.gh
three strains of Staphylococcus developed resistance to
penicillin of 1000, 4000, and 6000 times, the maximum
resistance obtainable by three strains of Pneumococcus
and a strain of Streptococcus pyogenes was 30 tim.es the
original. In addition there were indications that the
strains which became resistant simultaneously lose
virulence and this seemed to be of a permanent character*
Bondi and Dietz (1944) also investigated strains
of Staphylococcus aureus
.
Salmonella typhosa , and Proteus
vulgaris that v/ere m.ade more resistant to penicillin and
found that these organism.s did not produce penicillinase,
but were resistant due to some other mechanism.
Kirby (1944)^0 isolated 7 strains of staphylococci
that were naturally resistant to penicillin and each of
these 7 strains produced penicillinase.
-I p
Demerec (1945)-^ produ.ced penicillin resistant

staphylococci and this resistance was maintained hy
keeping the culture in the refrifjerator on an a£\ar
slant for three months. A discussion of the ori^jin of
resistance was also included v^ritb the conclusion that
it was due to development of mutants*
71Todd and Turner (1945) induced penicillin re-
sistance hy two strains of Staphylococcus aureus by
cultivating the organisms in increasing concentrations
of penicillin, and returned them nearly to their original
susceptibility by transfers in penicillin-free broth.
Miller and Bohnhoff (1945)^-^ grew gonococci in
increasing concentrations of penicillin and raised the
end point from. 0.02 units per ml to 21 units per ml.
A special technique of alternating the subcultures in
penicillin agar and penicillin-free agar was employed
to attain this resistance. By constant exposure to
penicillin the gonococci were able to reach a maximal re-
sistance of only 7.7 units per ml.
72Todd, Turner, and Drew (1945) increased the re-
sistance of Staphylococcus A to penicillin by repeated
subcultures in penicillin broth; 250-fold after 21
cultures, and 5,000-fold after 75 subcultures. The
Oxford H strain of Staphylococcus aureus was 3000 times
as resistant after 27 transfers and 5000 times as resistant
after 75 transfers. Both strain rapidly lost this acq-uired

resistance with subcultlvation in plain broth.
Using hemolytic streptococci as the test organism,
the resistance was five times the ori'-'inal after 35 sub-
cultures, and foujp times the original after 78 sub-
cultures. The drop to original sensitivity was slov/ and
required 76 subcultures in plain broth. There was con-
siderable up and down variation in end points in both
the rise and fall of resistance.
After 46 subcultures pneumococcus Type II became
26 times as resistant as originally and remained the
same after 114 subcultures in penicillin blood broth.
The penicillin fastness was maintained after 82 sub-
cultures without penicillin, indicating a permanent
fastness of pneumococcus to penicillin.
Miller and Bohnhoff (1945)^'^ also studied the
development of penicillin resistance by the meningococcus,
and the simultaneous effect on virulence. V/ith seven strains
ranging in natural resistance from 0,1 to 0,5 units per ml,
6 strains reached a resistance up to 5.0 units per ml
with no loss of virulence, v/hile the seventh strain reached
a resistance of 41 ujiits per ml, vi th a complete loss of
virulence at the resistance of 18 units per ml, but with
no loss of virulence up to 14 units per ml.
LiJiria (1946).^^ utilized a pour plate method for
determining the development of resistance of Staphylococcus
I
to penicillin. Dilutions of penicillin from 0 to 0,1
units per ml were utilized in the pour plates. The
number of colonies p;raduall7 diminished from the plates
containing no penicillin to no colonies in the plates
containing 0,1 units per ml. Colonies from the hi<;^hest
concentration of penicillin showing growth were used for
a second serial dilution pour agar test and these cultures
showed increased resistance over the original cultures.
Repeated such tests gave rising resistances. Some strains
required heavy inocula to get gtowth, indicating the possi
hility that penicillinase was produced and sufficient
inoculum was essential so that enough penicillinase to
inactivate the penicillin could be transferred,
/ N 19Graessle and Frost (1946) studied 6 strains of
staphylococci isolated from different sources for devel-
opment of resistance to penicillin and streptomycin and
other characteristics associated with resistance. They
found that all strains become resistant when exposed to
the antibiotics, that resistance was lost after trans-
ferring daily for seven days in nutrient broth or in
some instances by storage or dry ice (for penicillin only)
Resistance developed to penicillin in some cases showed
slight cross resistance to streptomycin, but the reverse
did not occur. The organisms developing resistance to

penicillin showed pleomorphism, slowing of metabolic
activities, and loss of pigmentation; comparable effects
were not found for streptomycin resistance except for an
occasional loss of pigmentation and a slowing in rate
of fermentation of sugars, but this was reversible after
removal of the organisms from streptomycin for a suffi-
cient period of time,
Yegian, Budd, and Middlebrook (1946)^^ studied
biologic changes in a sulfathiazole resistant strain of
Mycobacterium ranae . This strain, which was 200 times
as resistant as the parent strain, maintained its re-
sistance after 35 transfers in plain Long's Medium during
a 10-month period; it shov/ed cross resistance to sulfa-
nilamide, sulfapyridine , and sulfadiazine. There were
permanent color changes produced in the medium by the
resistant org-.nism as well as an increase in granularity
of the pellicle. Also the resistant strain grev; at a
rate approximately one half that of the parent strain.
There were, however, no changes in antigenicity or
morphology as a result of the increased resistance. One
observation was that there was a greater susceptibility
to antibacterial agents such as oxalic acid, nitric acid,
copper sulfate, phenol, etc., simultaneous with the rise
of resistance to sulfathiazole; this was explained by
the slower rate of growth.
I
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IClein (1947) tested 8 strains of staphylococci
and streptococci for the development of strains resistant
to penicillin and streptomycin. The end point of peni-
cillin and streptomycin inhibiting the strains was first
determined, and then varyin^^;;; concentrations of each anti-
biotic far in excess of the end noint were used for iso-
lating resistant organisms. The method consisted of ino-
culating 100 tubes of each concentration of antibiotic,
and recording the nijunber of positive cultures. Of the
8 strains tested in this manner with penicillin, none
developed resistant variants with a high degree of re-
sistance. Six strains were tested with streptomycin and
a total of 57 variants with resistance to high concentra-
tions developed.
Silver and Kempe (1947)"^^ studied the mechanism of
development of resistance to streptomycin using Escherichia
coli and Aerobacter aerogenes as test organisms. Their
experiments gave indications that a single strain when ex-
posed to the antibiotic included variants v/ith varying
degrees of resistance, from extre;nely susceptible to
highly resistant strains, and when the susceptible variants
were inhibited, the more resistant variants grew out.
Seligraann and Wassermann (1947)^^ induced resistance
to streptomycin by various organisms (Pseudomonas aeruginosa
.
Staphylococcus ai.^reus
.
Serratia marcescens , and several
I
strains of Salmonella) both In vitro and in vivo and
observed changes in biologic characteristics such as
loss of pigment production in some cases, permanent re-
sistance, and a slower rate of growth,
"76
Waksman (1947) discussed the development of
bacterial resistance to streptomycin favoring the selec-
tive mechanism (S) as the explanation of rise in resistance.
Miller and Bohnhoff (1947)^*^ studied 96 strains
of meningococcus and found that none were naturally re-
sistant to penicillin, but resistance was developed rapid-
ly "by repeated subculture in increasing concentrations of
penicillin, particularly if the inocula were heavy. Viru-
lence decreased with, the rise of resistance but was readily
restored by a few mouse passages. In vivo resistance in-
creased correspondingly with in vitro resistance. There
were slight, temporary morphological changes. Attempts
to demonstrate penicillinase and antigenic differences
betv/een parent and resistant strains failed.
Kushnick, Randies, Gray, and Birkeland (1947)^"^
found that strains of Escherichia coli, Pseudomona s
aeruginosa
, and Bacillus subtilis which became resistant
to 1000,8000, and 1000 micrograms per ml of streptomycin
respectively grew better and more rapidly in the presence
of streptomycin. A variant of B. subtilis would not grov/
in the absence of streptomycin.
I
V\feinstein and Tsao (1947) Induced resistance to
penicillin by several strains of Streptococcus pyogenes
from 4 to 32 times the original in 41 transfers. The
resistance returned to normal after 37 subcultures in
plain broth,
Klimek, Cavallito, and Bailey {1948)'^2 studied
the rises of resistance by Staphylococcus aureus to
various antibiotics. The development of resistance
to penicillin and the active principle of Asarum
canadense was rapid with fluctuations, and there were
accompanying morphological changes. Streptomycin-re-
sistance increased very ranidly but showed no morpho-
logical changes. There were moderate increases in
resistance to gliotoxin and pyocyanin. Those that
developed resistance only slightly were the active
principles of Arctiian minus and Allium sativum. .
Mercuric chloride and aspergillic acid yielded no
significant rise in resistance. In general there v/as
a rapid loss of resistance to penicillin and gliotoxin,
only a moderate reversal to streptomycin, and main-
tenance of resistance by Allium sativum and oyocyanin.
There was a slight cross resistance to streptomycin in
strains highly resistant to penicillin and slight cross
penicillin Resistance in streptomycin-res: stant cultures

Bellamy and Klimek (1948)^ revealed that variants
of Staphylococcus aureus '-hich became highly resistant
(60,000-fold) to penicillin changed their gram staining
properties, developed cocc-hacillus forms, produced
penicillinase, although penicillinase was not produced
in the same strain at a lower resistance level, showed
changes in fermentation reactions, and no longer re-
quired nicotinamide as an accessory growth factor,
Bellamy and Klim.ek (1948) revealed that strains
of Staphylococcus aureus which became resistant to peni-
cillin grew at about one-half the rate of the sensitive
parent strain aerobically and showed no appreciable
grov/th anaerobically . They also pointed out that organisms
such as Clostrldiimi perfrinrens
.
Streptococcus fecalis
,
and Streptococcus mastitic.i s that depended on anaerobic
processes for their energy supply will not develop
appreciable resistance to penicillin.
45
Paine and Finland (1948) obtained streptomycin-
resistant and streptomycin-dependent strains of Staphylo -
coccus aureus
,
Pseudomonas aeruf^inosa
, Escherichia cell
,
and Proteins morgani by a single exposure of large numbers
of "sensitive" organisms to high concentrations of strep-
tomycin. The resisti^nt and dependent strains represented
only a very small proportion of the total number of

or'-^anisms that had been exposed to the drug.
It was noted for a particular strain that the
sensitive and dependent cultures were inhibited at appro-
ximately the same concentrations. In other v/ords, the
dependent strain would cease to r^row in media containing
streptomycin in concentrations less than a given sjriount,
while the sensitive strain would be Inhibited in con-
centrations above that amount*
The mechanism was explained by the concept of the
action of antibacterial agents as metabolite antagonists.
Thus, in sensitive strains streptomycin can be considered
as interfering with some essential m.etabollte or meta-
bolic process, while in dependent strains, streptomycin
serves as an essential metabolite or growth factor.
Resistant strains nay be indifferent to the presence or
absence of streptomycin.

EXPERITiffiNTAL WORK
I, Methods and Materials
A, Test Organisms
Four strains of Staphyloco ecus aureus were
einployed In this study. The strains en:ployed were the
FDA strain #209, the Oxford strain obtained from the
American T^'-pe Culture Collection, L strain (Isolated
from a patient vn th a chronic mastoid infection), and
strain H 109 which was orlrlnally obtained from the
Merck Laboratories of Rahway, New Jersey,
B. Antibiotics
1, Penicillin
The penicillin employed was crystalline
penicillin G (Bristol) in vials of 100,000 unit amounts.
Dilutions were made v/lth sterile physiological saline
or sterile nutrient broth. Ten ml of the diluent were
added by pipette to the lyophlllzed penicillin yielding
a final concentration of 10,000 units per ml. Dil^jtlons
were then prepared in sterile broth so that concentra-
tions of 200, 20, 2, and 0.2 units per ml were obtained.
These dilutions were employed in the various titrations
to determine the end point of inhibition of the test
organisms
•
2. Bacitracin
The bacitracin was obtained from Dr. John
I
T, Goorley of Ben Venue Laboratories, Bedford, Ohio,
It was supplied in vials containing 10,000 units, and
dilutions \7ere made as with penicillin to final concen-
trations of 200, 20, 2, and 0.2 units per ml for titra-
tions •
C. Cultures
Stock cultures were maintained in the refri-
gerator on nutrient agar slants and transferred monthly.
Cultures used in assays were 18 to 24 hour nutrient
broth cultures '^rown at 57 C. Antibiotic control cul-
tures were prepared by inoculating 10 ml of nutrient
broth with 0.1 ml of a preceding 48 hour broth subcul-
ture of the original parent strain. Test cultures for
developing resistance were prepared by inoculating broth
with 0.5 ml of the end point tubes from the previous
titration. All cultures were diluted 1 to 500 in broth
for use in bacitracin and penicillin titrations. It
was estimated by plate counts that from 1/2 to 1 l/2
million bacteria were added uer inoculum varj^ing v/ith
the strain. It was observed that w^-en undilu.ted inocula
were used, growth was obtained in higher concentrations
of bacitracin than when the cultures were diluted as
above.
D. Technique for Titrating the Antibiotics
The method of titrating was identical for
bacitracin and penicillin, and consisted of a tube

dlliition technique. Orl3;inal assays were performed as
follows, and all other titrations were the same except
for variations in the range of the antibiotic:
(1) Concentrations of 2.0 and 0.2 units
per ml were prepared.
(2) Broth tubes were set up in 2 rows of
ten so that the first tube contained 1.8 ml of nutrient
broth, the second tube contained 1.7 ml, the third tube
contained 1.6 ml, etc., in decreasing amoimts of 0,1 m.l
to the tenth tube, which contained 0.9 ml of the broth.
The broth was distributed aseptically with a 5.0 ml
pipette or from a sterile burette.
(3) To the front rov; the 0.2 units per
ml dilution vras added as follows: 0.1 ml to the first
tube, 0.2 ml to the second tube, 0.3 ml to the third
tube, etc., increasing by 0.1 ml amounts so that 1.0 ml
was added to the tenth tube. The same technique was
applied to the back row except that 2.0 units pe r ml
was substituted for 0.2 ijnits per ml.
(4) Then 0.1 ml of an 18 to 24 hour
broth culture of the test organism was diluted in 50
ml of broth and 0.1 ml of the diluted culture was added
to the tubes containing the antibiotic. This gave final
concentrations of antibiotic ranging from 0.01 units per
ml in hundredths to 0.1 units per ml in the front row.
«<
and 0.1 to 1.0 units per ml In tenths in the back row.
In a like manner antibiotic concentrations from 1 to
10 and 10 to 100 could be used by employing 20 units
per ml and 200 units per ml respectively. Occasionally
antibiotic coneentrations between the usual concentra-
tions were used, e.g., 1 to 2, 0.1 to 0.2, 2 to 3, etc,
(5) The end point tube was that tube
containing the least amount of antibiotic and causing
complete inhibition of the test organisms after 24 hoiirs
at 37 C. It was noted that the length of time of incu-
bation affected the end ;-^oint, as an end point at 24
hours repeatedly increased to a higher end point in 48
hoixrs •
(6) A culture control tube containing 1,9
ml of the medium and 0.1 ml of the diliited culture accom-
panied the titration of each test organism.
(7) Bacitracin controls were run daily,
titrating the parent strain simultaneously with the
titration of each resistant organism. For example, on
the day that the resistant variant of L strain and strain
209 were run, an 18 to 24 hour broth culture of the parent
strains L and 209 were used in an accompanying titration.
At frequent intervals penicillin controls v/ere employed
in a like manner.
E. Method for Developing Increased Resistance to the
Antibiotic
•

1. Prelim5_nar7 Studies
Various methods were employed for Increasing
resistance, and one method was finally adopted as the most
suitable. The method consisted of: (a) transferring 0.1
ml from the tubes containing the highest concentration
of antibiotic and still yielding growth; (b) trans-
ferring 0.5 ml from the end point tubes; and (c) trans-
ferring 0,5 ml from various tubes containing higher con-
centrations of antibiotic than the end point tubes. These
transfers were made to 10,0 ml of nutrient broth and in-
cubated for growth or to pour agar plates from which
developing colonies were picleed for possible resistant
variants
•
2, Adopted Method
The technique finally accepted as the
most suitable for this study as a result of preliminary
observations was the transfer of 0,5 ml from the end
point tube to 10,0 ml of nutrient broth. All tubes
were incubated at 57 C for 18 to 24 hours, Grov/th was
almost invariably obtained from end point tubes by this
method. Simultaneously 0,1 ml transfers were made from
48 hour broth cultures of the original parent strains
to be used an antibiotic controls. Titrations were then
made using these cultures as the test organisms, and the
end point tubes, this time from a higher concentration
of antibiotic, were again transferred to nutrient broth
as before. The assa3''s were set up so that there were
t
I to 3 tubes below and 1 to 3 tubes above the previous
end point depending upon the circumstances.
P, Methods for Decreasing Resistance to the Anti-
biotic
Resistant cultures were treated in Tour ways
to return them to their original susceptibility to the
antibiotic. These methods consisted of maintaining
resistant cultures at room temperature, in the refri-
gerator and in the incubator at 37 C, and of daily trans-
fers in plain nutrient broth,
G, Cross Resistance
Cross resistance or sensitivity v/as determined
by titrating the strain resistant to one antibiotic
against the other antibiotic by the standard method used
in all the other assays,
II Results
A. Ori:^3*nal Titrations
The end points for bacitracin with the different
parent strains of Staphylococcus aureus were 0.2 units
per ml with the exception of the FDA strain #209 which
had an initial end point at 0.09 units per ml. The
initial end points with penicillin varied very sli[;:htly
for the four strains, the titers falling betv/een 0.03
and 0.06 ujiits per ml. Table I lists the four test
organism.s and their initial end points. The parent

TABLE I
Initial Titrations of h strains of Staphylococcus aureus
against bacitracin and penicillin
Organism End Points
Bacitracin Penicillin
Staphylococcus aureus 209 0,09 0,05
Staphylococcus aureus H 109 0.2 0.05
Staphylococcus aureus Oxford 0.2 0.03
Staphylococcus aureus L 0.2
' ' '
'
0.06

strains were being transferred every 48 hoi^rs and had
no exposure to the antibiotics except during the control
titrations to determine the potency of the antibiotic.
Despite lack of exposirre to bacitracin, there were con-
siderable variations in the end points with repeated
assays of the control cultures. These variations were
at first considered to be entirely due to decreases in
potency of the antibiotic, thus resulting in a rise in
the end p&int* Undoubtedly in some instances this was
the explanation for rises in titer, but this explanation
v/as insufficient to include all cases. Table Ii lists
a series of end points of bacitracin against repeated
titrations with the test organisms. At the onset of
this series a new vial of bacitracin was begun. The
first 10 or 11 titrations sho^red only slight variations,
probably within the limit of technical errors. Following
this group of determinations, the refrigerator, containing
the entire supply of bacitracin, broke down during the
weekend and it was feared that much of the potency of
all the bacitracin solution had been lost. An assay on
the following day, using the stored dilutions of 2 units
per ml, indicated that the bacitracin had not been affected
by this lack of refrigeration. The next two assays (12 and
13 for strains 209 and L; 13 and 14 for strains H 109 and
(Oxford) using the same stored dilutions indicated a marked
i
TABLE II
End Points in One Series of Bacitracin Control Titrations
Assay
Nuniber
Strain of Staphylocoocus aureus
209 L H 109 Oxford
1 0.1 not begxm 0.2 0.2
2 0.3 0.3 < 0.1 <0.1
3 not run not run
;
0.2
k < 0.1 0.2 0.2
i
0.2
3 0.09
_
0.3 0.2 * 0.2
6 0.1 0.2 0.3 ' "6.S
7 0.08 0.2 0.2 0.2
8 0.08 0.2 0.2
i
0.2
9 0.1 0.3 0.3 ' 0.2
10 ' not run not run 0.2 « 0.2
refrigerator breakdown over weekend of 27-28 December, and all
bacitracin was in the refrigerator
» •
11 1 0.08 0.2 0.2 ! <ro.i
12 1 0.2 o.U 0.2 \ 0.2
13 0.2 0.5 0.3 0.2
0.3* > 0.6* > o.i+ > O.U
15 0.3 y- 0.5 y- 0.5* i O.I].*
16 0.3 0.3
17 0.3 o.h 0.6 1 0.5
IS 0.2 0.3 0.5
19 0.2 0.2 0.3
j
0.2
So (a) 0.3 old
(b) 0.3 new
|
Ca; e.2
old
(b) 6,2
n&vf
The figures are end points in units per ml
* Re-diluted from stock solution containing 1000 units per ml
Began use of a new vial of lyophilized bacitracin
old - Diluted to 20 units per ml prior to refrigerator stoppage
new - Prepared from most recent vial of bacitracin
-.0
I
loss of potency. The following titration was made after
re-diluting the stock solution of 1000 units per ml up
to 2 units per ml. This assay also shovred a considerable
loss of bacitracin activity. A fresh vial of lyophilized
bacitracin was then started. The first three or fo^or
assays with the new vial surprisingly save results com-
parable with the preceding titrations indicating that
there was also a loss of strength in the lyophilized
antibiotic. Following this the results seemed to show a
return to normal for all stored bacitracin, indluding
the most recently started vial, the previous stock solu-
tion, and the previous dilute solutions. Thus, a de-
crease of potency of bacitracin cannot explain the short
period in which there was a rise of end point for the
control cultuj?es, since if this were the case, there
could be no return toward the original lower end point.
No explanation for these variations can be offered in
the present study, as further investigation with this
problem v/ould be necessary for any conclusions to be
reached.
Assays on penicillin gave no variations
of this sort with the control cultures.
B. Rise of Resistance
1. Preliminary Series
In this series one strain of organism

(staphylococcus aureus H 109) was carried through 20 trans-
fers of penicillin and the resistance to penicillin developed
from an original end point of 0.05 units per ml to a maximum
of 10.0 units per ml which is a 200-fold increase. Table
III and Graph 1.
For bacitracin two strains (h 109 and 209) run in
duplicate (I and II) on alternate days were studied in this
series. These v;ere carried to 30 transfers and the resistance
rose from ori^-inal end points of 0.2 units per ml (one was
0.1 units per ml) to maxima of 3,0 to 7.0 units per ml, varying
with the strain and particular titration. The increase in
resistance ranged from 10 fold to 66,67-fold in this group
with many up and down variations in all instances. The re-
sults of this study are summarized in Table III, One series
(H 109 II and 209 II) of each strains in this bacitracin re-
sistance study was carried on in the later studied. During
this series it v/as concluded that each titration for deve-
loping resistance required an accompanying assay of the
parent strain as a bacitracin control. This was not done
in all cases of the preliminary series, as in some instances
the control assay employed v/as the one performed on the pre-
vious day. The rise of resistance curves for bacitracin are
shov/n in Figujres 2 and 3, and the penicillin c^jrve is shown
in Figure 1. These results show that bacitracin fastness
develops at a much slower rate than penicillin fastness,
and that the bacitracin resistance rises in a straight line,
although there were many variations in the end points.
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2, Later Studies
In the later studies four strains of
Staphylococc us aureus (H 109, 209, Oxford, and L) were
used for development of resistance to both bacitracin
and penicillin. Results of these experiments are sim-
marized in Tables IV A and B, and are shown graphically
in Figures 4, 5, 6, and 7. These results confirm the
results of the earlier studies, and show that the rise
of resistance to penicillin is more rapid than the rise
of resistance to bacitracin. The rise of resistance
graphs for bacitracin were all similar with the exception
of the Oxford strain, which appeared to develop very
little or no resistance throuf;h 35 transfers (Figure 5) ,
The maximum titer observed with the Oxford strain against
bacitracin over the original was a 3-fold increase during
the 35 exposures. Strains H 109 and 209 rose to a maximal
increased resistance of 80- and 120-fold respectively with
63 exposures for the former and 62 transfers for the latte:
(Figure 4) . The L strain of Staphylococcus aureus a^'i-^ears
to follow the rise of resistance of strains H 109 and 209
with a 20-fold increase in 19 transfers, followed by a
levelling off. There appears to be a levelling off of
resistance between the 30th and 50th exposures at a
resistance 6f approximately 50 times the original for
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I
strain H 109 and at aboTit the GO-lold resistance level
for strain 209, althou-^h there appears to "be a secondary
rise with strain 209 after the 50th exposure. Figure 5 A
is a composite of three strains (L, H 109 and 209) of
Staphylococcus aureus in percentap-e of T:'eak resistance to
bacitracin. The Oxford strain did not develop any appre-
ciable resistance and was, therefore, not included in
the composite.
The rise of resistance to Denicillln appears to be
slightly more rapid and to a somewhat greater extent than
bacitracin. The maximal titer obtained for any one of
the strains using bacitracin was 120 tim.es the original
titer, and this occurred after 62 transfers, and for
one strain only (strain 209); whereas, the maximal titer
obtained for penicillin was 400 times the original titer
and this occurred after only 32 transfers, also with
strain 209. In addition, all strains rose to at least
100 times the original resistance to penicillin, and not
more than 31 transfers were required in any instance,
v/hile only one strain, as m.entioned above, reached 100-
fold resistance to bacitracin. The rise in resistance
to penicillin is shown in tabular form in Table IV B
and graphically in Figures 6 and 7. All four strains
appeared to attain their maximal resistance to penicillin
at approximately 30 exposures, and this was followed by
a slight decrease for a few transfers. This drop was for
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Rise in Penicillin Re stance in Percentaf^e of Peak ap-.ainst Number of
Number of Exposures
Fienire 7 A

a short time only, since a second rise seemed to be com-
mencing just prioi' to the discontinuation of the rise in
resistance studies. Fi,p;ure 7 A is a comr)osite of the
four strajns of Staphylococcus ai-'reus in percentage of
peak resistance to penicillin.
C, Drop of Resistance
1. Preliminary Series
Penicillin only vras studied in the pre-
liminary series. The drop in resistance to penicillin
by Staphylococcus aureus E 109 was rapid by all methods
employed. It was slightly more rapid by dally transfers
of the penicillin resistant strains through plain nutrient
broth than by maintaining the culture at either incubator,
refrigerator, or room temperature, and was slightly slower
by maintenance at room temperature than by the other
methods. The culture maintained in the refrigerator
dropped at a more rapid rate than the one maintained at
room temperatijj-e, but was slov/er than the other two.
The results are siammarized in Table V and illustrated in
Figure 8. It can be seen that, from a titer of 160,0
times the natural end point with that organism, there was
a drop towards normal so that the titer was nearly at its
original level in from 14 to 39 days varying with the
type of treatment of the resistant culture.
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I
2. Later Studies
Drop in resistance studies with bacitracin
Indicate that there is a fairly rapid drop toward normal
if the cultures are being transferred daily in plain
nutrient broth in the absence of bacitracin. The
results are summarized in Table VI and shown graphi-
cally in Figures 9 A, 9 B, and 9 C, It can be seen
that for strain H 109 there is a rapid decrease in re-
sistance from 40 times to 10 times the original in 7
daily transfers, followed by slower drops to 8 and 6
times after 14 and 21 transfers respectively. Strain
209 dropped very rapidly from 120 times its original
resistance to 30 times the original resistance in 7
transfers, and it finally reached 20 times its original
resistance after 29 transfers in plain nutrient broth.
Strain L gave a different picture; its drop was only
slight at the beginning, dropping from about 11 to
a]x)ut 8.5 times the original resistance in 7 days,
shov/ing a return to 10 after 14 transfers so that the
decrease in resistance remained only very slight. In
21 days there appeared to be a slight rise to 13,3 times
the original resistance.
Looking at the same table and graphs, we
find that there was little or no drop in resistance fol-
lowing storage in the refrigerator of all three strains.
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strain H 109, bep*5.nning at 40 times the orip;inal re-
sistance, remained at this figure after 29 da^^s of
storap;e. Strain 209 remained at 120 times its ori-
ginal resistance after 13 days in the refrigerator
and dropped to only 100 times after 29 days of storage*
Strain L again maintained its resistance v/ith a drop
from approximately 11 to 10 tim.es the original re-
sistance in 14 days, but shov;ed a maiked decrease to
3.3 times the original after 21 days of storage.
The results v;ith penicillin v/ere similar
for decreasing resistance by daily transfers of the
resistant cultures in penicillin-free broth; but there
was a marked difference in the effects on storage in
the refrigerator betv/een penicillin and bacitracin. The
penicillin-resistant cultures in all cases showed rapid
drops in resistance both by storage in the refrigerator
and by daily transfers in plain nutrient broth, although
the latter was slightly m.ore rapid. The results for
decrease in resistance to penicillin are summarized in
Table VII and Figija?es 10 A, B, and C. It can be seen
that strain 209 dropped rapidly from 200 times to 2
tim.es the original resistance after 16 transfers, and
to its original resistance after only 21 transfers in
plain broth. The stored culture dropped to 20 times the
original after 16 days in the refrigerator. The Oxford
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strain decreased Its resistance from 66,7 times the
original to 10 and 2 tines the original in 14 and 15
daily transfers respectively, v/hile the stored culture
dropped to 13.5 times the original in 14 da^^s of re-
frigeration. Strain L lost its resistance at a slightly
slower rate than the other two, as the cultijre that was
being transferred daily in nutrient broth dropped from
150 to 16.7 times its original resistance in 14 days,
and the refrigerated culture dropped to 33,3 in 14 days.
D. Cross Resistance
1, Preliminary Studies
Penicillin alone was included in this
series. The resu.lts of bacitracin titers accompanying
the rise and fall of penicillin resistance is summarized
in Table VIII and illustrated in Figures 11 A and B,
There appears to be a decrease in bacitracin resistance
accompanying the rise in penicillin resistance. The
original end point of this strain for bacitracin was
0,2 units per ml of bacitracin, 'Vhen the resistance to
penicillin reached 80 times the original, the bacitracin
titer dropped below 0.06 units per ml. At penicillin
titers of 180 and 160 the bacitracin titer dropped to
0.03, With the drop of penicillin resistance, there
v/as a rise of bacitracin resistance toward its original
end point. There was no rise in bacitracin titer toward
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normal by the resistant cult^jre that was maintained in
the refrigerator despite the drop in penicillin resistance.
2, Later Studies
As the resistance to bacitracin rose, there
was no corresponding rise, but there appeared to be a
slight drop in resistance to penicillin for 2 out of 3
strains, shown in Talile IX. "Nhen the bacitracin resistance
of strain H 109 was betvi/een 52 and 50 tines its original
resistance, the penicillin titers ran between 0.02 and
0.03 units per ml, while the control titers were in the
range of 0,04 and 0.03 units per ml. For strain L the
difference in penicillin titers v;as less marked since the
test assays gave end points ranging from 0.05 to 0.07
units per ml, while the control showed end points of 0.07
and 0.08. There was, however, no indication of either
increase or decrease of penicillin resistance accompanying
increased resistance to bacitracin by strain 209. In a
range of bacitracin resistance from 50 to over 125, all
assays with penicillin gave end points of bacitracin
resistant cultures that were identical v/ith the control.
The penicillin resistant cnltu.res gave
evidence of being markedly altered in bacitracin suscep-
tibility. The results of the assays of penicillin-re-
sistant strains against bacitracin are summarized in
Tables X, XI, XII, and XIII, and are represented graphi-
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cally In Figures 12, 13, and 14. These tables and r^raT^hs
confirm the nreliminary stodies by showing that as the
penicillin resistance of a strain of Staphylococcus aureus
increases, there 5. s a simultaneous greater sus oeptihi lit^T-
to "bacitracin. As the penicillin resistance returns
toward normal, there is an concomitant return toward
normal of the bacitracin titers v;ith the exce-^.tion of
those cultures that have been refrigerated. The peni-
cillin-resistant cultures that were maintained in the
refrigerator lose their penicillin resistance nearly as
rapidly as those that are transferred daily in plain
nutrj.ent broth, but the greater susceptibility to baci-
tracin appears to be riore permanent since there is no
accompanying return tov/ard the normal titer.
The greater s^is ceptibility to bacitracin
of penicillin r-'sistant cultures is not necessarily a
specific phenomenon. Studies with other agents revealed
that penicillin resistant strains became more susceptible
to these agents in some instances. Table XIV shows that
penicillin-resistant variants of strains H 109, L, and
209 become more susceptible to copper sulfate as well as
bacitracin, and strain 209 Increased its susceptibility
to bichloride of mercury also. Strain H 109 did not
alter its susceptibility to m.ercuric chloride, and the
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Oxford strain changed its end point for neither bichloride
of merciirynor copper sulfate, although its penicillin
resistance rose and its bacitracin resistance dropped.

DISCUSSION
This study indicates that there is a rela-
tively slow hut steady rise of resistance to hacitracin
by three out of four strains of Staphylococcus aureus
,
and the increase in resistance of these three follov/s
a generally similar pattern. The fourth strain (the
Oxford strain) gave no appreciable rise in resistarce,
the maximum attained during 35 exposures being 3-fold,
Tv/o strains (H 109 and 209) were carried to 63 and 62
exposures respectively, and attained maximum resistance
levels of 80 and 125 respectively. These tv^o strains
at about the 25th or 30th exposure showed a tendency
to level off in their rise of resistarce at about 50
to 60 times the original resistances.
In contrast to the rise of resistance to
bacitracin, the rise of resistance to penicillin was
much more rapid and far greater. Strain 209 rose to
a maximupi of 400 times its original resistance in 32
exposures, strain H 109 rose to a maximum of 100 times
in 32 transfers, and 200 times after 20 transfers in
two separate runs, the Oxford strain and L strain
reached peaks of 100 and 166.67 in 31 and 30 transfers
respectively.
The decrease in resistance of strains that
1I
became resistant by repeated exposure v/as also studied.
Cultures that were made resistant to bacitracin would
rapidly lose this resistance by transferring the cultures
daily in nlain nutrient broth so that in 29 days there
was a "gradual return nearly to normal. Ylhen, hov/ever,
the bacitracin-resistant variants were maintained in
broth at refrigerator temperatures, there was no appre-
ciable loss of resistance in 2 out of 3 strains.
Penicillin s'Howed a slightly different
behavior in drop of resistance studies. All 4 strains
that were studied showed a gradual decrease :n resis-
tance acproaching the orif^inal le^^'el whether the
cultures were refrigerated or transferred daily up to
21 days.
There v-ras only a very sl5 "^ht tendency for
bacitracin-resistant variants to affect the penicillin
titers by resulting in a very little increase in sus-
ceptibility to penicillin. In contrast the penicillin-
resistant cultures yielded a marked rise in suscep-
tibility to bacitracin, so that strains which were ori-
ginally inhibited at 0.2 units per ml of bacitracin
would become altered so that less than 0,01 units per ml
could prevent growth under otherwise identical conditions.
This susceptibility of penicillin-fast strains to baci-
tracin became greater as the T)entcillin resistance rose.

and it decreased as the resistance to pen.lcillln decreased
with the exception of those cultures that were refrigerated.
The penicillin-resistant variants, that v;ere maintained
in the refrirrerator, lost their resistance to penicillin
hut maintained their increased susceptibility to hacitracin.
The increased susceptibility to bacitracin of
penicillin-fast strains was not specific, as in some in-
stances this increased susceptibility was also exhibited
to other chemical a,{^ents, namely copper sulfate and
bichloride of mercury. The reason for this increased
susceptibility of resistant variants may be due to a
decreased rate of growth,as suggested by Yegian, Budd,
and Middlebrook.
The parent cultures were assayed each day along
with the test cultures as bacitracin controls. There were
considerable variations in the end points of these con-
trols v^ith the same strain. The reason for this variation
has not been determined. It was at first considered to
be due to decreases in potency of the bacitracin, but con-
tinued study indicated that this was not a complete explana-
tion, as using the same lot of bacitracin there would be
a period at a certain level, followed by a rise in end
point, and this followed by a subsequent retijrn to normal.
The possibility?" of some change in the culture was considered,
but discarded, since it was unlikely that three or four

strains would simultaneously pror'uce sMch a chann;e.
This explanation at first seemed logical, as It was
previously shown that heavier Inocula of the sa^.e strains
yielded higher end points than the li-hter Inocula, and
fluctuations in growth might produce cultuj'es that were
not constantly of the same density*

SIMMARY
The relative curve in rise of resistance by four
strains of Stanhylococ ens aureus usinpr penicillin
and baci'^racin as antibiotics v/as determined^
It was shown that penicillin developed resistance
more rapidly and to a greater degree than did
bacitracin.
There was a tendency for the rise of resistance to
bacitracin to level off after 25 to 30 exposures
at 50 to 90 times the original resistance.
Loss of resistance to penicillin developed rapidly
by various methods of treatment, such as daily trans-
fer in penicillin-free broth, storage in broth at
room temperature, in the incubator, and in the
refrigerator
•
Loss of resistance to bacitracin was very raold if
the resistant cultures v/ere transferred daily in
bacitracin-free nutrient broth; but there was little
or no decrease in bacitracin resistance following
storage of the resistant cultures in the refrigerator
up to 29 days.
Cross resistance studies with bacitracln-resistant
cultures indicated that there was either no change
in penicillin resistance or onl^'" a very slight de-
crease in the penicillin titers.

Cross resistance studies with penicillin-resistant
strains indicated that as the resistance rose for
penicillin, the organism became more susceptible
to bacitracin. Conversely, as the resistance to
penicillin decreased toward the ori.«;inal, the re-
sistance to bacitracin rose toward its orin-inal
point. This phenomenon was not entirely specific
as in some instances the penicillin-resistant
cultures also showed an increased susceptibility
to mercuric chloride and copper sulfate.
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1
The purpose of this paper v/as to compare the rise
in resistance curves by Staphylococciis aureus to penicillin
and bacitracin, showing; the relative rate and extent of dru,^
fastness to these two antibiotics. The curves showing drop
in resistance and the phenomenon of cross resistance were als
to be investigated.
Many investigators hau'e demonstrated that Staphylo
coccus aureu.s develops resistance rapidly to penicillin by
repeated exposures to Increasing concentrations of the drLig,
It has also been shown that microorganisms become resistant
to many otber antibiotics, notably streptomycin, both in
vitro and in vivo > In general these induced resistances
have been rapidly lost by transferring the cultures through
a plain broth medium in the absence of the antibiotic. In
some cases of streptomycin resistance, orgarism.s have de-
veloped not only a permanent resistance but an actual de-
pendence upon the drug as an essential or accessory growth
factor.
Several antibiotic substances in addition to
bacitracin have been isolated from strains of Bacillus
subtilis « Bacitracin has been shorm, however, to be one of
the most promising of these antibiotics, and it has been
one of the most extensively studied of this group. Studies
on bacitracin have included m.ethods of isolation and puri-

fication
,
sone cMnical evaluation, and various chemical
and pharriacolo£;;ical properties including acute and chronic
toxicity. The study of increases in resistance to bacitracin
by susceptible orc^inisns has, hov;ever, not as yet been reported/
Pour strains of Staphylococcus aureu.s ( H 109,
PDA 209, L, and Oxford) were used for this study. The peni-
cillin v/as commercial crystalline Penicillin G, and the
bacitracin was a commercial product obtained through the
courtesy of the Ben Venue Laboratories at Bedford, Ohio,
Titrations with both antibiotics v/ere m_ade using
each strain to determine the initial end points of each
organism to be stu.died. End point is defined as the least
amount of antibiotic caiising complete inhibition in growth
of the test organisms,
Reiistance was induced by transferring 0,5 ml of
the end point tube to 10,0 ml of nu.trient broth, and after
incubation for 18 to 24 hours to obtain growth, the sub-
culture was titrated to determine the new, higher end
point. Repetitions of this procedure were employed to
yield higher and higher end points.
Decreases in resistance v/ere produced by main-
taining a broth culture at refrigerator or other temperatures
or by daily transfers in plain nutrient broth.
Cross resistance studies Y;ere made by determining
the end point to one antibiotic of a culture resistant to
the other antibiotic. For example, penicillin-resistant

cultiu?es can be assayed with bacitracin in order to deter-
mine whether or not there is any increase or decrease in
resistance to bacitracin as compared v/ith the parent strain.
Other unrelated chemicals, such as bichloride of mercury or
copper sulfate can then be tested for this property in order
to investin;ate the possibility that any variation mi.^ht be
non-specifi c.
This study indicates that there is a relatively
slow but steady rdse of resistance to bacitracin by three
out of four strains of Staphylococcus aureus , and the in-
crease in resistance of these three follows a generally
similar pattern. The fourth strain (the Oxford strain)
gave no appreciable rise in resistance, the maximum attained
during 35 exposures being 3-fold, Two strains ( H 109 and
209) were carried to 63 and 62 Exposures respectively, and
attained maxT.mum resistance levels of 80 and 125 respectively.
These two strains at about the 25th or 30th exposure shovred a
tendency to level off in their rise of resistance at about
50 to 60 times the original resistances.
In contrast to the rise of resistance to bacitracin
the rise of resistance to penicillin was much more rapid and
far greater. Strain 209 rose to a maximum of 400 times its
original resistance in 32 exposures, strain H 109 rose to a
maxim.um of 100 times in 32 transfers, and 200 times after 20
transfers in bv/o separate runs, the Oxford strain and L strain
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reached peaks of 100 and 166.67 in 31 and -"50 transfers
respectively.
The decrease in resistance of strains that hecame
resistant by repeated exposure was also sLudied, Cultures
that were made resistant to bacitracin would rapidly lose
this resistance by transferrin;-^ the cultures daily in nlain
nutrient broth so that in 29 days t^o.ere was a ,f;;radual return
to normal. Vifhen, however, the bacitracin-resistant variants
were maintained in broth at refrigerator temperatures, there
was no appreciable loss of resistance in 2 out of 3 strains.
Penicillin shov/ed a sli:;htly different behavior
in drop of resistance studies. All 4 strains that were studied
showed a .gradual decrease in resistance approaohinc; the orir^inal
level whether the cultujres were refrigerated or transferred
daily up to 21 days.
There was only a very slight tendency for bacitracin-
resistant variants to affect the pericillin titers by resulting
in a very little increase in susceptibility to penicillin.
In oaontrast the penicillin-resistant cultures yielded a marked
rise in susceptibility to bacitracin, so that strains v/hich
were originally inhibited at 0.2 units per ml of bacitracin
vjould become altered so that less than 0,01 i:jnits per ml
could prevent grov/th under otherwise identical conditions.
This susceptibility of penicillin-fast strains to bacitracin
became greater as the penicillin resistance rose, and it

decreased as the resistance to penicillin decreased with the
exception of those cultures that were refrigerated. The
penicillin-resistant variants, that vrere malntalnec' in the
refrigerator, lost their resistance to penicillin but r-ain-
talned their increased susceptibility to bacitracin.
The increased susceptibility to bacitracin of
penicillin-fast strains vras not specific, as in some instances
this increased susceptibility v/as also exhibited to fcther
chenical af^ents, na^.ely copper sulfate and bichloride of
mercury. The reason for this increased susceptibility of
resistant variants may be due to a decreased rate of (growth
as suggested by Yeglan, Budd , and I.Iiddlebrook,
The parent cultures were assayed each day along
with the test cultures as bacitracin controls. There m'ere
considerable variations in the end points of these controls
with the same strains. The reason for this variation kas not
been determined. It was at first considered to be due to de-
creases in potency of the bacitracin, but continued study
indicated that this was not a complete explanation, as using
the same lot of bacitracin there would be a period at a
certain level, follov/ed by a rise in end point, and this
follov/ed by a subsequent return to normal. The possibility
of some change in the culture was considered, but discarded,
since it v/as unlikely that three or four strains vfould
simultaneously produce such a change. This explanation at

first seemed lo,<:|;ical, as it was previously shown that heavier
lnocv0.a of the same strains yielded hi';>;her end points than the
lighter inocnla, and f li^ctiiations in ^i^owth mi,^ht produce
cultures that were nob constantly of the same density.
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